ArticleNature2024
Accurate structure prediction of biomolecular interactions with AlphaFold 3.
Abstract read
In one paragraph
Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8,431 papers.
0numbers the graph read from it
0cells of the map it votes in
8,431citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8,431 citing papers in PubMed.
- Gentamicin and d-serine selective pressure to improve the homogeneity of cells expressing target proteins.Synthetic and systems biotechnology · 2027Article
- Artificial intelligence catalyzes antimicrobial peptide design.Synthetic and systems biotechnology · 2027Review
- Reprogramming the enduracidin NRPS assembly line via thioesterase domain relocation.Synthetic and systems biotechnology · 2027Article
- Deep Learning-driven synergistic engineering of PET hydrolase for post-consumer PET depolymerization.Synthetic and systems biotechnology · 2027Article
- Evolution of alcohol oxidase for improved methanol bioconversion and formaldehyde tolerance.Synthetic and systems biotechnology · 2027Article
- VCP at the crossroads of UPS and autophagy in cancer.Genes & diseases · 2027Review
- Discovery of novel murine PML isoforms.Nucleus (Austin, Tex.) · 2026Article
- Modulation of GSNOR activity for improved NO homeostasis and flood resilience in plants.Plant signaling & behavior · 2026Review
- Attenuating ETEC virulence using a heat-labile enterotoxin-blocking binding protein.Gut microbes · 2026Article
- Article
- Genetic and enzymatic basis of xylooligosaccharide metabolism byGut microbes · 2026Article
- Sequence and ionic requirements of pUG fold quadruplexes.RNA biology · 2026Article
- Crosstalk between RNA secondary and three-dimensional structure prediction: a comprehensive study.RNA biology · 2026Article
- Gene therapy for hereditary hematological disorders: From clinical breakthroughs to future horizons.Molecular therapy. Nucleic acids · 2026Review
- MultilevelCurrent research in structural biology · 2026Article
- The ROCK1 PHC1 domain mediates recruitment to Rho activity zones and contractility signaling.Life science alliance · 2026Article
- Article
- Mapping the TNFR2-targeting antibody patent landscape: Insights from macro trends to structural signatures.Human vaccines & immunotherapeutics · 2026Article
- Article
- The interaction between CfAda3 and CfGcn5 impacts growth, development, and virulence ofVirulence · 2026Article
8,371 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
48 authors.
Josh Abramson *Core Contributor, Google DeepMind, London, UK.ORCID 0009-0000-3496-6952
Jonas Adler *Core Contributor, Google DeepMind, London, UK.ORCID 0000-0001-9928-3407
Jack Dunger *Core Contributor, Google DeepMind, London, UK.
Richard Evans *Core Contributor, Google DeepMind, London, UK.ORCID 0000-0003-4675-8469
Tim Green *Core Contributor, Google DeepMind, London, UK.ORCID 0000-0002-3227-1505
Alexander Pritzel *Core Contributor, Google DeepMind, London, UK.ORCID 0000-0002-4233-9040
Olaf Ronneberger *Core Contributor, Google DeepMind, London, UK.ORCID 0000-0002-4266-1515
Lindsay Willmore *Core Contributor, Google DeepMind, London, UK.ORCID 0000-0003-4314-0778
Andrew J BallardCore Contributor, Google DeepMind, London, UK.ORCID 0000-0003-4956-5304
Joshua BambrickCore Contributor, Isomorphic Labs, London, UK.ORCID 0009-0003-3908-0722
Sebastian W BodensteinCore Contributor, Google DeepMind, London, UK.
David A EvansCore Contributor, Google DeepMind, London, UK.
Chia-Chun HungCore Contributor, Isomorphic Labs, London, UK.ORCID 0000-0002-5264-9165
Michael O'NeillCore Contributor, Google DeepMind, London, UK.
David ReimanCore Contributor, Google DeepMind, London, UK.ORCID 0000-0002-1605-7197
Kathryn TunyasuvunakoolCore Contributor, Google DeepMind, London, UK.ORCID 0000-0002-8594-1074
Zachary WuCore Contributor, Google DeepMind, London, UK.ORCID 0000-0003-2429-9812
Akvilė ŽemgulytėCore Contributor, Google DeepMind, London, UK.
Eirini ArvanitiGoogle DeepMind, London, UK.
Charles BeattieGoogle DeepMind, London, UK.ORCID 0000-0003-1840-054X
Ottavia BertolliGoogle DeepMind, London, UK.ORCID 0000-0001-8578-3216
Alex BridglandGoogle DeepMind, London, UK.
Alexey CherepanovIsomorphic Labs, London, UK.ORCID 0000-0002-5227-0622
Miles CongreveIsomorphic Labs, London, UK.
Alexander I Cowen-RiversGoogle DeepMind, London, UK.
Andrew CowieGoogle DeepMind, London, UK.ORCID 0000-0002-4491-1434
Michael FigurnovGoogle DeepMind, London, UK.ORCID 0000-0003-1386-8741
Fabian B FuchsGoogle DeepMind, London, UK.
Hannah GladmanGoogle DeepMind, London, UK.
Rishub JainGoogle DeepMind, London, UK.
Yousuf A KhanGoogle DeepMind, London, UK.ORCID 0000-0003-0201-2796
Caroline M R LowIsomorphic Labs, London, UK.
Kuba PerlinGoogle DeepMind, London, UK.
Anna PotapenkoGoogle DeepMind, London, UK.
Pascal SavyIsomorphic Labs, London, UK.
Sukhdeep SinghGoogle DeepMind, London, UK.
Adrian SteculaIsomorphic Labs, London, UK.ORCID 0000-0001-6914-6743
Ashok ThillaisundaramGoogle DeepMind, London, UK.
Catherine TongIsomorphic Labs, London, UK.ORCID 0000-0001-7570-4801
Sergei YakneenIsomorphic Labs, London, UK.ORCID 0000-0001-7827-9839
Ellen D ZhongGoogle DeepMind, London, UK.ORCID 0000-0001-6345-1907
Michal ZielinskiGoogle DeepMind, London, UK.
Augustin ŽídekGoogle DeepMind, London, UK.ORCID 0000-0002-0748-9684
Victor BapstCore Contributor, Google DeepMind, London, UK.
Pushmeet KohliCore Contributor, Google DeepMind, London, UK.ORCID 0000-0002-7466-7997
Max JaderbergCore Contributor, Isomorphic Labs, London, UK. jaderberg@isomorphiclabs.com.ORCID 0000-0002-9033-2695
Demis HassabisCore Contributor, Google DeepMind, London, UK. dhcontact@google.com.ORCID 0000-0003-2812-9917
John M JumperCore Contributor, Google DeepMind, London, UK. jumper@google.com.ORCID 0000-0001-6169-6580
Funding
No grant is acknowledged in the PubMed record.
Abstract
The introduction of AlphaFold 2
Indexed as
Deep LearningLigandsModels, MolecularProteinsSoftwareAntibodiesAntigensHumansIonsMolecular Docking SimulationNucleic AcidsProtein BindingProtein ConformationReproducibility of ResultsAntibodiesAntigensIonsLigandsNucleic AcidsProteins
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.